AzTrials
AzTrials

Intensive Care Unit PatientsIPOS-ICUNCT07004920

Adaptation and Validation of a Patient-centered Outcome Scale for People in the Intensive Care Unit (IPOS-ICU)

An observational study of Intensive Care Unit Patients, run by Heinrich-Heine University, Duesseldorf at 1 site in Germany.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The focus of intensive care is on survival and the prolongation of life. The care of organ systems takes priority and is assessed through screening tools such as the Sequential Organ Failure Assessment (SOFA) score, which evaluates clinical and laboratory factors associated with prognosis. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intensive Care Unit Patients
What is being tested?
IPOS-ICU
How many people
500 participants
Where
1 siteGermany
Study dates
1 Nov 2025to Jun 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients aged above 18 years in the ICU will be screened for inclusion.

Who may be able to join

  • Adult ICU patients
  • written informed consent from patient or health-care proxy

Who cannot join

  • age < 18 years
  • Language barrier (communication in German/local language or English not possible).
  • ICU discharge 24h after admission
  • no written consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Germany1 site
  • University Hospital Düsseldorf

    Düsseldorf, North Rhine-Westphalia, 40225

Other trials in Germany

About this study

The focus of intensive care is on survival and the prolongation of life. The care of organ systems takes priority and is assessed through screening tools such as the Sequential Organ Failure Assessment (SOFA) score, which evaluates clinical and laboratory factors associated with prognosis. Despite advancements in modern intensive care, the hospital mortality rate for mechanically ventilated patients in 2022 was approximately 43%. Even for survivors of intensive care, post-intensive care syndrome poses a significant burden on quality of life.

Although intensive care and palliative care often appear to be contradictory, clinical overlap between these populations is common, with both experiencing physical, psychosocial, and spiritual challenges that frequently require input from specialized teams. Nevertheless, palliative care remains underrepresented in German intensive care units (ICUs), with only 1.4% of ICU patients on prolonged mechanical ventilation receiving specialist palliative care. Therefore, the identification of patients in need of palliative care and the reduction of barriers such as limited resources and varying clinician attitudes must be addressed. This necessitates a robust tool for measuring and assessing palliative care needs specifically in ICU patients, enabling the implementation of interventions aimed at minimizing the burden on patients, families, and treating clinicians, as well as guiding appropriate allocation of healthcare resources.

Read more

The Integrated Palliative Care Outcome Scale (IPOS) questionnaire was developed as a patient-centered measurement instrument from a palliative care perspective. IPOS enables the assessment of symptoms and needs from the viewpoint of patients and their families. For patients with COVID-19, an adapted version-IPOS-COV-was developed, wherein healthcare personnel assess patient symptoms and needs. However, no existing instrument comprehensively captures the physical, psychosocial, and spiritual needs of ICU patients and their families from a palliative care perspective. Such a tool could facilitate both the identification of patients requiring palliative care and serve as an endpoint for evaluating the effectiveness of palliative care interventions in ICU settings, including post-discharge outcomes related to post-intensive care syndrome affecting both patients and families.

The underlying hypothesis is that a patient-centered measurement instrument addressing physical, psychosocial, and spiritual needs from a palliative care perspective for ICU patients can be developed and validated based on the IPOS. Additionally, demographic data, clinical course, ICU interventions (e.g., mechanical ventilation, dialysis, palliative care consultations, family discussions, and therapy goal limitations), as well as SOFA scores and Palliative Phase of Illness (PPoI) classifications at the time of IPOS-ICU assessment, will be collected. It is hypothesized that IPOS-ICU scores will correlate with disease severity (as measured by SOFA and PPoI) and poor ICU outcomes, including length of stay, mortality, and discharge location. Furthermore, it is hypothesized that interventions such as palliative care consultations will be associated with lower IPOS-ICU scores. In the first phase of the study, an international and multiprofessional expert panel with experience in both intensive and palliative care will adapt the IPOS questionnaire for ICU patients, resulting in the development of the IPOS-ICU. The following modification strategies will be applied: rewording, removal, addition of items, adjustment of recall periods, and inclusion of a "cannot assess" response option. Online meetings will be conducted with representatives from Germany, Switzerland, the United Kingdom, the Czech Republic, and the United States. A larger review team will then evaluate the adapted version, and an informal "comfort consultation" will be conducted in ICU settings to ensure that the IPOS-ICU is considered appropriate and acceptable by ICU staff. Following adaptation, the validation phase will be conducted using a multicenter design. After obtaining informed consent from study participants, the IPOS-ICU will be administered at designated time points identified during the adaptation process. ICU staff (including at least one nursing professional and one medical professional) will complete the IPOS-ICU. The questionnaire will include an assessment of the PPoI (categorized as stable, unstable, deteriorating, dying, or deceased), and a free-text field for recording the estimated number of hours spent with the patient. Electronic Case Report Forms will capture demographic data, SOFA scores, treatment details, and outcomes following ICU discharge, all extracted from medical records. This study holds significant relevance by addressing the gap between the identification of palliative care needs and the actual implementation and evaluation of palliative care in ICU settings.

Being tested
IPOS-ICU

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IPOS-ICUOther

    This is a prospective observational study. Health care providers will be asked to will out the IPOS-ICU for patients in the intensive care unit.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. IPOS-ICU total score

    The primary outcome is the IPOS-ICU and its descriptive analysis. Each of the IPOS-ICU items will have the following units of measure: Not at all (0), Slightly (1), Moderately (2), Severely (3), Overwhelmingly (4), Cannot assess (e.g. unconscious). The investigators will calculate the total score of the IPOS-ICU at each time point of assessment.

    Measured: during the intervention

Secondary outcomes (11)
  1. Number of positive IPOS-ICU items

    The investigators will determine the incidence of total positive (items with unit >1) items and the total of cannot assess answers.

    Measured: during the intervention

  2. Palliative Phase of Illness (PPoI)

    Categories: stable, unstable, deteriorating, dying, or deceased

    Measured: during the intervention

  3. SOFA score

    The Sequential Organ Failure Assessment (SOFA) score is a clinical tool used to assess the extent of a patient's organ dysfunction in the ICU. It evaluates six organ systems: respiratory, cardiovascular, hepatic, coagulation, renal, and neurological. Each system is scored from 0 (normal function) to 4 (most severe dysfunction), resulting in a total score ranging from 0 to 24.

    Measured: during the intervention

  4. Days of mechanical ventilation

    Number of days of invasive mechanical ventilation via either an endotracheal tube or tracheal cannula in the ICU.

    Measured: immediately after the intervention

  5. Days of ECMO

    Number of days of extracorporeal membrane oxygenation (ECMO, VV (veno-venous), VA (veno-arterial), and VVA (veno-veno-arterial)) in the ICU.

    Measured: immediately after the intervention

  6. Days of dialysis

    Number of days of renal replacement therapy in the ICU.

    Measured: immediately after the intervention

  7. ICU length of stay

    Number of days in the ICU.

    Measured: immediately after the intervention

  8. ICU mortality

    % of patients dying in the ICU.

    Measured: immediately after the intervention

  9. ICU discharge location

    ICU discharge to the following categories: Hospital unit, other ICU in the hospital, external ICU, skilled nursing facility, rehabilitation unit, palliative care unit, hospice, home, or other.

    Measured: immediately after the intervention

  10. Functional status at ICU discharge

    Categorized as: fully independent, partially dependent, or fully dependent.

    Measured: immediately after the intervention

  11. Clinical Frailty Scale (CFS) at ICU discharge

    The Clinical Frailty Scale is a 9-point scale used to assess a patient's level of frailty based on physical fitness and functional status. It ranges from 1 (Very Fit) to 9 (Terminally Ill). Higher scores indicate worse outcomes, representing greater frailty and increased vulnerability to adverse events, including mortality and poor recovery.

    Measured: immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2025
  2. Study start1 Nov 2025 (estimated)
  3. Primary completion1 May 2026 (estimated)
  4. Study completionJun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07004920
Sponsor's protocol ID
2025-3146
Other IDs
2025-3146
Acronym
IPOS-ICU
Status last verified
Jan 2025
First submitted
30 Apr 2025
Last updated
4 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Intensive Care Unit Patients, run by Heinrich-Heine University, Duesseldorf at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Theresa Tenge, MD (+49 2118118451, theresa.tenge@med.uni-duesseldorf.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

IPOS-ICU total score (time frame: during the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in